Mustgrow Biologics Corp Stock Buy Hold or Sell Recommendation
| MGRO Stock | 1.10 0.05 4.76% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding MustGrow Biologics Corp is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell MustGrow Biologics Corp given historical horizon and risk tolerance towards MustGrow Biologics. When Macroaxis issues a 'buy' or 'sell' recommendation for MustGrow Biologics Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out MustGrow Biologics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as MustGrow and provide practical buy, sell, or hold advice based on investors' constraints. MustGrow Biologics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
MustGrow |
Execute MustGrow Biologics Buy or Sell Advice
The MustGrow recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on MustGrow Biologics Corp. Macroaxis does not own or have any residual interests in MustGrow Biologics Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute MustGrow Biologics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Good | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
MustGrow Biologics Trading Alerts and Improvement Suggestions
| MustGrow Biologics may become a speculative penny stock | |
| MustGrow Biologics appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 4.71 M. Net Loss for the year was (676.94 K) with loss before overhead, payroll, taxes, and interest of (190.72 K). | |
| MustGrow Biologics generates negative cash flow from operations | |
| Latest headline from news.google.com: MustGrow Announces Grant of RSUs and DSUs - StockTitan |
MustGrow Biologics Returns Distribution Density
The distribution of MustGrow Biologics' historical returns is an attempt to chart the uncertainty of MustGrow Biologics' future price movements. The chart of the probability distribution of MustGrow Biologics daily returns describes the distribution of returns around its average expected value. We use MustGrow Biologics Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of MustGrow Biologics returns is essential to provide solid investment advice for MustGrow Biologics.
| Mean Return | 0.36 | Value At Risk | -6.67 | Potential Upside | 6.76 | Standard Deviation | 4.21 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of MustGrow Biologics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
MustGrow Biologics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to MustGrow Biologics or Chemicals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that MustGrow Biologics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a MustGrow stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.21 | |
β | Beta against Dow Jones | 1.23 | |
σ | Overall volatility | 4.17 | |
Ir | Information ratio | 0.06 |
MustGrow Biologics Volatility Alert
MustGrow Biologics Corp shows above-average downside volatility for the selected time horizon. MustGrow Biologics Corp is a potential penny stock. Although MustGrow Biologics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in MustGrow Biologics Corp. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on MustGrow instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.MustGrow Biologics Fundamentals Vs Peers
Comparing MustGrow Biologics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MustGrow Biologics' direct or indirect competition across all of the common fundamentals between MustGrow Biologics and the related equities. This way, we can detect undervalued stocks with similar characteristics as MustGrow Biologics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MustGrow Biologics' fundamental indicators could also be used in its relative valuation, which is a method of valuing MustGrow Biologics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MustGrow Biologics to competition |
| Fundamentals | MustGrow Biologics | Peer Average |
| Return On Equity | -0.12 | -0.31 |
| Return On Asset | 0.012 | -0.14 |
| Profit Margin | (0.09) % | (1.27) % |
| Operating Margin | 0.02 % | (5.51) % |
| Current Valuation | 50.07 M | 16.62 B |
| Shares Outstanding | 51.64 M | 571.82 M |
| Shares Owned By Insiders | 10.78 % | 10.09 % |
| Number Of Shares Shorted | 12.86 K | 4.71 M |
| Price To Book | 14.47 X | 9.51 X |
| Price To Sales | 11.51 X | 11.42 X |
| Revenue | 4.71 M | 9.43 B |
| Gross Profit | (190.72 K) | 27.38 B |
| Net Income | (676.94 K) | 570.98 M |
| Total Debt | 618.41 K | 5.32 B |
| Book Value Per Share | 0.07 X | 1.93 K |
| Cash Flow From Operations | (294.76 K) | 971.22 M |
| Short Ratio | 0.33 X | 4.00 X |
| Beta | 1.66 | -0.15 |
| Market Capitalization | 54.22 M | 19.03 B |
| Total Asset | 6.94 M | 29.47 B |
| Retained Earnings | (23.28 M) | 9.33 B |
| Working Capital | 5.73 M | 1.48 B |
| Net Asset | 6.94 M |
MustGrow Biologics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as MustGrow . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 216.52 | |||
| Daily Balance Of Power | 1.0 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 1.1 | |||
| Day Typical Price | 1.1 | |||
| Price Action Indicator | 0.03 | |||
| Period Momentum Indicator | 0.05 |
About MustGrow Biologics Buy or Sell Advice
When is the right time to buy or sell MustGrow Biologics Corp? Buying financial instruments such as MustGrow Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having MustGrow Biologics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Healthcare theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for MustGrow Stock Analysis
When running MustGrow Biologics' price analysis, check to measure MustGrow Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MustGrow Biologics is operating at the current time. Most of MustGrow Biologics' value examination focuses on studying past and present price action to predict the probability of MustGrow Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MustGrow Biologics' price. Additionally, you may evaluate how the addition of MustGrow Biologics to your portfolios can decrease your overall portfolio volatility.